1. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes
   Wenshuang Jia et al, 2023, EPMA Journal CrossRef
2. Exposure to Low-Frequency Radiation Changes the Expression of Nestin, VEGF, BCRP and Apoptosis Markers During Glioma Treatment Strategy: An In Vitro Study
   Maryam Amirinejad et al, 2024, Current Radiopharmaceuticals CrossRef
3. Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review
   Martin A. Merenzon et al, 2023, Nitric Oxide CrossRef
4. Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
   Natalia Oddone et al, 2020, Frontiers in Pharmacology CrossRef